Cargando…

Effectiveness of Netarsudil versus Brimonidine in Eyes already Being Treated with Glaucoma Medications at a Single Academic Tertiary Care Practice: A Comparative Study

BACKGROUND: Rho kinase inhibitors, such as netarsudil, are a relatively new class of medications recently introduced into the market for the treatment of glaucoma, the leading cause of irreversible blindness in the world. Previous clinical trials have studied netarsudil's efficacy when used as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pham, Alex T., Bradley, Chris, Casey, Corinne, Jampel, Henry D., Ramulu, Pradeep Y., Yohannan, Jithin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792385/ https://www.ncbi.nlm.nih.gov/pubmed/36582193 http://dx.doi.org/10.1016/j.curtheres.2022.100689

Ejemplares similares

Effectiveness of Netarsudil as an Additional Therapy for Glaucoma in Patients Already on Maximally Tolerated Medical Therapy
por: Villegas, Natacha C, et al.
Publicado: (2021)

Predicting eyes at risk for rapid glaucoma progression based on an initial visual field test using machine learning
por: Shuldiner, Scott R., et al.
Publicado: (2021)

Netarsudil Increases Outflow Facility in Human Eyes Through Multiple Mechanisms
por: Ren, Ruiyi, et al.
Publicado: (2016)

Differences in visual field loss pattern when transitioning from SITA standard to SITA faster
por: Le, Christopher T., et al.
Publicado: (2022)

Factors Predicting a Greater Likelihood of Poor Visual Field Reliability in Glaucoma Patients and Suspects
por: Aboobakar, Inas F., et al.
Publicado: (2020)

Brimonidine in the treatment of glaucoma and ocular hypertension
por: Cantor, Louis B
Publicado: (2006)

Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma
por: Lin, Cheng-Wen, et al.
Publicado: (2018)

Prediction of MIGS outcomes on second eyes using first eyes’ response
por: Dickinson, Anna, et al.
Publicado: (2023)

Netarsudil-Induced Corneal Flattening in a Child with Secondary Open-Angle Glaucoma
por: Ganesh, Durga, et al.
Publicado: (2022)

Randomized Trial of Brinzolamide/Brimonidine Versus Brinzolamide Plus Brimonidine for Open-Angle Glaucoma or Ocular Hypertension
por: Gandolfi, Stefano A., et al.
Publicado: (2014)

A Randomized, Phase 2 Study of 24-h Efficacy and Tolerability of Netarsudil in Ocular Hypertension and Open-Angle Glaucoma
por: Peace, James H., et al.
Publicado: (2020)

Netarsudil-associated epithelial keratopathy
por: Ramakrishnan, Meera S., et al.
Publicado: (2020)

Effects of the Glaucoma Drugs Latanoprost and Brimonidine on Corneal Temperature
por: Konieczka, Katarzyna, et al.
Publicado: (2019)

The Efficacy, Safety, and Satisfaction Associated with Switching from Brinzolamide or Brimonidine to Brinzolamide/Brimonidine in Open-Angle Glaucoma Patients
por: Onoe, Hiromitsu, et al.
Publicado: (2022)

Fluorimetric Quantification of Brimonidine Tartrate in Eye Drops
por: Sunitha, G., et al.
Publicado: (2013)

Pooled Efficacy and Safety Profile of Netarsudil Ophthalmic Solution 0.02% in Patients With Open-angle Glaucoma or Ocular Hypertension
por: Singh, Inder P., et al.
Publicado: (2020)

Profile of netarsudil ophthalmic solution and its potential in the treatment of open-angle glaucoma: evidence to date
por: Dasso, Lily, et al.
Publicado: (2018)

Impact of Glaucoma and Dry Eye on Text-Based Searching
por: Sun, Michelle J., et al.
Publicado: (2017)

Brinzolamide/Brimonidine Fixed Combination: Simplifying Glaucoma Treatment Regimens
por: Moosavi, Reza, et al.
Publicado: (2018)

Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
por: Araie, Makoto, et al.
Publicado: (2021)

A novel fixed-combination timolol-netarsudil-latanoprost ophthalmic solution for the treatment of glaucoma and ocular hypertension
por: Wang, Tao, et al.
Publicado: (2022)

Clinical efficacy and neuroprotective effects of brimonidine in the management of glaucoma and ocular hypertension
por: Galanopoulos, Anna, et al.
Publicado: (2009)

Brimonidine prevents neurodegeneration in a mouse model of normal tension glaucoma
por: Semba, K, et al.
Publicado: (2014)

Netarsudil-associated reticular corneal epithelial edema
por: Tran, Jennifer A., et al.
Publicado: (2022)

Reticular corneal epithelial edema with topical netarsudil
por: Parmar, Dipali P., et al.
Publicado: (2023)

A deep learning model incorporating spatial and temporal information successfully detects visual field worsening using a consensus based approach
por: Sabharwal, Jasdeep, et al.
Publicado: (2023)

Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focus
por: Nguyen, Quang H
Publicado: (2014)

Evaluation of brimonidine-timolol fixed combination in patients of primary open-angle glaucoma
por: Joshi, Sachin R, et al.
Publicado: (2013)

Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma
por: Zhao, Yujin, et al.
Publicado: (2022)

Fixed-Dose Combination of Netarsudil and Latanoprost in Ocular Hypertension and Open-Angle Glaucoma: Pooled Efficacy/Safety Analysis of Phase 3 MERCURY-1 and -2
por: Asrani, Sanjay, et al.
Publicado: (2020)

Pragmatic adjunctive usage of netarsudil: A retrospective chart review from a tertiary care center
por: Goergen, Nate S, et al.
Publicado: (2022)

Trials are already being prioritised, just not at the institutional level
por: Kolstoe, Simon
Publicado: (2017)

The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans
por: Kazemi, Arash, et al.
Publicado: (2018)

Formulation and evaluation of stimuli-sensitive hydrogels of timolol maleate and brimonidine tartrate for the treatment of glaucoma
por: Dubey, Akhilesh, et al.
Publicado: (2014)

The Effect of Brimonidine 0.1% on Disc Hemorrhage in Primary Open-Angle Glaucoma Patients
por: Nitta, Koji, et al.
Publicado: (2020)

The Efficacy, Safety and Satisfaction Associated with Switching from Brinzolamide 1% and Brimonidine 0.1% to a Fixed Combination of Brinzolamide 1% and Brimonidine 0.1% in Glaucoma Patients
por: Onoe, Hiromitsu, et al.
Publicado: (2021)

Respiratuvar depression after accidental nasal ingestion of brimonidine eye drops in infant
por: Gunes, Ali, et al.
Publicado: (2016)

Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension
por: Wang, Ningli, et al.
Publicado: (2020)

Netarsudil monotherapy as the initial treatment for open-angle glaucoma and ocular hypertension in Indian patients: A real-world evaluation of efficacy and safety
por: Mathur, Manoj Chandra, et al.
Publicado: (2023)

Already!
Publicado: (1892)

Cannot write session to /tmp/vufind_sessions/sess_acm3hf5r47u030b7fuhauj5hv6